segunda-feira, 23 de setembro de 2013

Siemens named company of the year by Frost & Sullivan in Molecular Imaging


Siemens named company of the year by Frost & Sullivan

Siemens Healthcare has been recognized with the 2013 North American Frost & Sullivan Award for Company of the Year, for its work in the molecular imaging market, the company announced this week.

Frost & Sullivan bestows the award on leading companies that demonstrate product innovation and growth strategies that result in market success. Siemens earned the award through its slew of innovative releases in both PET and SPECT.

"Having recognized many years ago that the future of medical imaging would hinge on more advanced and efficient hybrid imaging modalities, Siemens Healthcare has built a legacy of industry firsts," said Frost & Sullivan Industry Principal Nadim Michel Daher in a release. "Today, as the result of this continuous technology and product advancement, Siemens Healthcare is leading the way in the imaging industry with regard to each of the SPECT/CT, PET/CT and PET/MR imaging modalities." 

Siemens was also acknowledged for its work with radiopharmaceuticals, particularly amyloid imaging agents for the evaluation of Alzheimer's and other cognitive diseases. Siemens' PETNET Solutions allows customers to use the same company for equipment as well as radiopharmaceutical distribution. 
Fonte: SNMMI SmartBrief

Nenhum comentário:

Postar um comentário